GlaxoSmithKline’s head of R&D Patrick Vallance is reportedly leaving the firm to take on the role of chief scientific advisor at the government. More: GSK’s R&D chief to leave for UK gov role? Source: News
read moreNovartis has submitted an application to the European Medicines Agency for its CAR-T therapy CTL019 for two haematological indications. More: Novartis files CAR-T therapy in Europe Source: News
read moreMerck and Pfizer have launched in the UK of Bavencio, the first medicine to be licensed for the treatment of the rare, aggressive skin cancer of metastatic Merkel Cell Carcinoma (mMCC). More: Merck, Pfizer launch Bavencio for rare skin cancer
read more© 1994 - 2026 B.M. Pharmaceuticals